Anxiety and depressive symptoms in fibromyalgia are related to poor perception of health but not to pain sensitivity or cerebral processing of pain

Arthritis and Rheumatism

Volumn 62, Issue 11, 2010, Pages 3488-3495

  Jensen, Karin B ^a   Petzke, Frank ^b   Carville, Serena ^c   Fransson, Peter ^a   Marcus, Hanke ^b   Williams, Steven C R ^c   Choy, Ernest ^c   Mainguy, Yves ^d   Gracely, Richard ^e   Ingvar, Martin ^a   Kosek, Eva ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; BECK DEPRESSION INVENTORY; COPING STRATEGY QUESTIONNAIRE; DEPRESSION; DISEASE CLASSIFICATION; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MOOD DISORDER; NOCICEPTION; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; SHORT FORM 36; STATE TRAIT ANXIETY INVENTORY; STIMULATION; VISUAL ANALOG SCALE;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANALYSIS OF VARIANCE; ANXIETY; DEPRESSION; FEMALE; FIBROMYALGIA; HEALTH STATUS; HUMANS; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PERCEPTION; QUESTIONNAIRES;

EID: 78249278824     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27649     Document Type: Article

References (45)

1. Craig AD,. A new view of pain as a homeostatic emotion. Trends Neurosci 2003; 26: 303 - 7.
2. Merskey H, Bogduk N,. Classification of chronic pain. 2nd ed. Seattle: IASP Press; 1994. p. 209 - 14.
3. Godinho F, Magnin M, Frot M, Perchet C, Garcia-Larrea L,. Emotional modulation of pain: is it the sensation or what we recall? J Neurosci 2006; 26: 11454 - 61.
4. Ploghaus A, Narain C, Beckmann CF, Clare S, Bantick S, Wise R, et al. Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci 2001; 21: 9896 - 903.
5. Edwards RR, Bingham CO III, Bathon J, Haythornthwaite JA,. Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases. Arthritis Rheum 2006; 55: 325 - 32.
6. De Souza JB, Potvin S, Goffaux P, Charest J, Marchand S,. The deficit of pain inhibition in fibromyalgia is more pronounced in patients with comorbid depressive symptoms. Clin J Pain 2009; 25: 123 - 7.
7. Bair MJ, Robinson RL, Katon W, Kroenke K,. Depression and pain comorbidity: a literature review. Arch Intern Med 2003; 163: 2433 - 45.
8. Baliki MN, Chialvo DR, Geha PY, Levy RM, Harden RN, Parrish TB, et al. Chronic pain and the emotional brain: specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain. J Neurosci 2006; 26: 12165 - 73.
9. Schweinhardt P, Kalk N, Wartolowska K, Chessell I, Wordsworth P, Tracey I,. Investigation into the neural correlates of emotional augmentation of clinical pain. Neuroimage 2008; 40: 759 - 66.
10. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L,. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19 - 28.
11. Kosek E, Ekholm J, Hansson P,. Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 1996; 68: 375 - 83.
12. Kosek E, Hansson P,. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 1997; 70: 41 - 51.
13. Lautenbacher S, Rollman GB,. Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 1997; 13: 189 - 96.
14. Gracely RH, Petzke F, Wolf JM, Clauw DJ,. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002; 46: 1333 - 43.
15. Jensen KB, Kosek E, Petzke F, Carville S, Fransson P, Choy E, et al. Evidence of dysfunctional pain inhibition in fibromyalgia reflected in rACC during provoked pain. Pain 2009; 144: 95 - 100.
16. Staud R,. Fibromyalgia pain: do we know the source? Curr Opin Rheumatol 2004; 16: 157 - 63.
17. Goldenberg DL,. The interface of pain and mood disturbances in the rheumatic diseases. Semin Arthritis Rheum 2010; 40: 15 - 31.
18. Wessely S, Hotopf M,. Is fibromyalgia a distinct clinical entity? Historical and epidemiological evidence. Baillieres Best Pract Res Clin Rheumatol 1999; 13: 427 - 36.
19. Giesecke T, Gracely RH, Williams DA, Geisser ME, Petzke FW, Clauw DJ,. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 2005; 52: 1577 - 4.
20. Gracely RH, Geisser ME, Giesecke T, Grant MA, Petzke F, Williams DA, et al. Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 2004; 127: 835 - 43.
21. Bantick SJ, Wise RG, Ploghaus A, Clare S, Smith S, Tracey I,. Imaging how attention modulates pain in humans using functional MRI. Brain 2002; 125: 310 - 9.
22. Song GH, Venkatraman V, Ho KY, Chee MW, Yeoh KG, Wilder-Smith CH,. Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls. Pain 2006; 126: 79 - 90.
23. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160 - 72.
24. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J,. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561 - 71.
25. Bartels E, Dreyer L, Jacobsen S, Jespersen A, Bliddal H, Danneskiold-Samsoe B,. Fibromyalgia, diagnosis and prevalence: are gender differences explainable? Ugeskr Laeger 2009; 171: 3588 - 92. In Danish.
26. Yunus MB,. The role of gender in fibromyalgia syndrome. Curr Rheumatol Rep 2001; 3: 128 - 34.
27. Petzke F, Clauw DJ, Ambrose K, Khine A, Gracely RH,. Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation. Pain 2003; 105: 403 - 13.
28. American Psychiatric Association. Diagnostic and statistical manual of mental disorders DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; 1994.
29. Spielberger CD,. Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto: Consulting Psychologists Press; 1983.
30. Rosenstiel AK, Keefe F,. The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment. Pain 1983; 17: 33 - 44.
31. Ware JE Jr, Sherbourne CD,. The MOS 36-item Short-Form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473 - 83.
32. Burckhardt CS, Clark SR, Bennett RM,. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991; 18: 728 - 33.
33. Frackowiak RS, Friston KJ, Frith C, Dolan R, Price C, Zeki S, et al. Human brain function. San Diego: Academic Press; 2004.
34. Ingvar M,. Pain and functional imaging. Philos Trans R Soc Lond B Biol Sci 1999; 354: 1347 - 58.
35. Tracey I,. Nociceptive processing in the human brain. Curr Opin Neurobiol 2005; 15: 478 - 87.
36. Evans AC, Marrett S, Neelin P, Collins L, Worsley K, Dai W, et al. Anatomical mapping of functional activation in stereotactic coordinate space. Neuroimage 1992; 1: 43 - 53.
37. Tracey I, Mantyh PW,. The cerebral signature for pain perception and its modulation. Neuron 2007; 55: 377 - 91.
38. Drevets WC,. Functional neuroimaging studies of depression: the anatomy of melancholia. Annu Rev Med 1998; 49: 341 - 61.
39. Leffler AS, Kosek E, Lerndal T, Nordmark B, Hansson P,. Somatosensory perception and function of diffuse noxious inhibitory controls (DNIC) in patients suffering from rheumatoid arthritis. Eur J Pain 2002; 6: 161 - 76.
40. Kosek E, Jensen K, Carville S, Choy E, Gracely RH, Ingvar M, et al. All responders are not the same: distinguishing Milnacipran-from placebo-responders using pressure pain sensitivity in a fibromyalgia clinical trial [abstract]. Pain in Europe V: Fifth Congress of the European Federation of IASP Chapters (EFIC); 2009 Sept 9-12; Istanbul, Turkey.
41. Ehrlich G,. Fibromyalgia, a virtual disease. Clin Rheumatol 2003; 22: 8 - 11.
42. Arnold LM, Rosen A, Pritchett YL, D?souza DN, Goldstein DJ, Iyengar S, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005; 119: 5 - 15.
43. Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 2008; 136: 432 - 44.
44. Arnold BS, Alpers GW, Suss H, Friedel E, Kosmutzky G, Geier A, et al. Affective pain modulation in fibromyalgia, somatoform pain disorder, back pain, and healthy controls. Eur J Pain 2008; 12: 329 - 38.
45. Petzke F, Harris RE, Williams DA, Clauw DJ, Gracely RH,. Differences in unpleasantness induced by experimental pressure pain between patients with fibromyalgia and healthy controls. Eur J Pain 2005; 9: 325 - 35.